Paradigm Biopharmaceuticals Ltd.ASX: PAR

PAR Receives US Ethics Approval for Phase 3

May 15, 2025 at 2:45 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment